The Technical Analyst
Select Language :
Applied Therapeutics Inc [APLT]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Applied Therapeutics Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Applied Therapeutics Inc is listed at the  Exchange

-0.73% $6.80

America/New_York / 28 mar 2024 @ 16:00


Applied Therapeutics Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 720.03 mill
EPS: -1.420
P/E: -4.79
Earnings Date: May 08, 2024
SharesOutstanding: 105.89 mill
Avg Daily Volume: 2.22 mill
RATING 2024-03-28
C+
Sell
RATINGS
Rating CashFlow: Neutral
Return On Equity: Strong Buy
Return On Asset: Strong Sell
DE: Strong Sell
P/E: Sell
Price To Book: Strong Sell
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/an/an/a
Gr.Profitn/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -4.79 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.81x
Company: PE -4.79 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$1.197
(-82.40%) $-5.60
Date: 2024-03-29
Expected Trading Range (DAY)

$ 6.11 - 7.49

( +/- 10.10%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-14 Shendelman Shoshana Sell 318 573 Common Stock
2024-03-14 Perfetti Riccardo Sell 110 804 Common Stock
2024-03-14 Hansard Adam Sell 48 871 Common Stock
2024-03-14 Funtleyder Leslie D. Sell 28 727 Common Stock
2023-12-28 Chinoporos Constantine Buy 300 000 Common Stock
INSIDER POWER
42.68
Last 98 transactions
Buy: 24 718 894 | Sell: 4 549 161

Forecast: 16:00 - $6.80

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $6.80
Forecast 2: 16:00 - $6.80
Forecast 3: 16:00 - $6.80
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $6.80 (-0.73% )
Volume 1.435 mill
Avg. Vol. 2.22 mill
% of Avg. Vol 64.77 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Applied Therapeutics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Applied Therapeutics Inc

RSI

Intraday RSI14 chart for Applied Therapeutics Inc

Last 10 Buy & Sell Signals For APLT

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35sell$2.71N/AActive
Profile picture for
            Applied Therapeutics Inc

APLT

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy. Its preclinical stage products include AT-003 for the treatment diabetic retinopathy; AT-104, a PI3K inhibitor for treating orphan hematological oncology T Cell Acute Lymphoblastic Leukemia. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.

Last 10 Buy Signals

Date Signal @
RADUSDMar 29 - 08:24$3.39
XVSUSDMar 29 - 08:20$16.04
SAVAXUSDMar 29 - 08:1961.03
RSS3USDMar 29 - 08:190.550
STETHUSDMar 29 - 08:193 528.46
P2PSUSDMar 29 - 08:18202.45
NAKAUSDMar 29 - 08:192.12
MNTUSDMar 29 - 08:191.160
KASUSDMar 29 - 08:200.137
JOEUSDMar 29 - 08:190.872

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.